Therefore, we cautiously hypothesise that the opposite responses of L1CAM in tumour cells and normal ECs may be due to the dual nature of Myc (i.e., checkpoint signalling activation and survival in cancer cells vs. genomic instability in normal cells). The gene discussed is L1CAM; the disease is cancer.